The Patent Finder

Catalent Ontario Limited

8 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 5, 2027
    The maintenance fee for Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof (US 10,463,637) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof (US 11,896,566) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
  • 1 fee due Nov 7, 2027
    The maintenance fee for Pharmaceutical Formulations of Statins and OMEGA-3 Fatty Acids for Encapsulation (US 11,975,108) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,480,667Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof
In force
 · High confidence
In forceHigh confidence
US 11,896,566Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof
In force
 · High confidence
In forceHigh confidence
US 10,463,637Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof
In force
 · High confidence
In forceHigh confidence
US 12,605,348Pharmaceutical Formulations of Naproxen for Soft Gel Encapsulation and Combinations Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,173,125Multiphase Soft Gel Capsules, Apparatus and Method Thereof
In force
 · High confidence
In forceHigh confidence
US 11,975,108Pharmaceutical Formulations of Statins and OMEGA-3 Fatty Acids for Encapsulation
In force
 · High confidence
In forceHigh confidence
US 12,544,341Methods of Preparing Multiphase Statin and OMEGA-3 Fatty Acid Soft Capsule Formulations
In force
 · Low confidence
In forceLow confidence
US 9,844,512Multi Phase Soft Gel Capsules, Apparatus and Method Thereof
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited